Novartis Czech Republic made a net profit of CZK 71.0 mil with revenues of CZK 6,312 mil in 2017, down by 6.08% and down by 1.25%, respectively, compared to the previous year. This translates into a net margin of 1.12%.
Historically, between 2000 - 2017, the firm’s net profit reached a high of CZK 82.7 mil in 2015 and a low of CZK 2.15 mil in 2000. Since 2012, the firm's net profit has increased 42.1% or 7.27% a year on average.
On the operating level, EBITDA reached CZK 138 mil, down 18.9% compared to the previous year. Over the last five years, company's EBITDA has risen 14.6% a year on average.
You can see all the company’s data at Novartis Czech Republic profile, or you can download a report on the company in the report section.